LGVNNasdaq

Longeveron Inc.

Healthcare·Cardiovascular·Phase 2·Miami, FL, United States
Cardiovascular

Longeveron Inc. (LGVN): 2 pipeline candidates · 2 upcoming catalysts · ~11 mo cash runway · 1 clinical trial. Updated within the last hour.

5.7/10

BioSniper Score

5-factor signal · derived from public data

Cash Runway3.1

11.0 months

Financial Health9.0

D/E 0.32

Pipeline Maturity6.0

Lead: Phase 2

Pipeline Breadth4.6

2 candidates

Catalyst Momentum6.0

2 upcoming, next in ~44d

Insider SignalN/A

N/A

A transparent, data-derived signal for Longeveron Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$25.0M

Cash

$15.8M

Quarterly Burn

$4.4M

Runway

11.0 mo

Revenue

$398K

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~May 2027
Today~12 mo out
Catalyst within runway

Pipeline (2 candidates)

Upcoming Catalysts (2)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

30

Total value held

$2.7M

HolderSharesValue
vanguard capital management llc1,084,064$1.1M
millennium management llc446,725$465K
blackrock, inc.224,198$233K
geode capital management, llc203,618$212K
adar1 capital management, llc200,000$208K
jane street group, llc185,656$193K
state street corp45,380$47K
vanguard fiduciary trust co38,715$40K
capital investment advisory services, llc26,525$28K
commonwealth equity services, llc25,155$26K

Showing top 10 of 30 institutional holders of Longeveron Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

1 clinical trial·2 FDA decisions·CEO: Mr. Stephen H. Willard Esq.

Frequently asked questions

How many drug candidates are in Longeveron Inc.'s pipeline?

Longeveron Inc. (LGVN) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Longeveron Inc.'s next catalyst?

Longeveron Inc.'s next tracked catalyst is a Phase2_Topline event — "Phase 2 Readout: laromestrocel" — expected August 1, 2026.

What is Longeveron Inc.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, Longeveron Inc. has approximately 11.0 months of cash runway.

What is Longeveron Inc.'s market capitalization?

Longeveron Inc.'s market capitalization is approximately $25.0M.

Who is the CEO of Longeveron Inc.?

Mr. Stephen H. Willard Esq. is the chief executive officer of Longeveron Inc. (LGVN).

Get the full picture on Longeveron Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.